Used for reconstituted peptide: The 28-day timeline applies to the reconstituted peptide solution see BPC-157 Shelf Life & Expiration FAQ for the peptide-specific context
Associate Professor, Human Nutrition Canada Research Chair Tier 2 in Micronutrients and Human Health The University of British Columbia The 2025 update was underwritten, in part, by a grant from Balchem Corporation
Free radicals also contribute to aging and diseases like cancer
For non-statin therapy, it means adding cost, complexity, injections in some cases, and a thinner evidence base for decades of use in low-risk people
For instance, in the BRIDGE trial comparing DMF alone to a compound containing DMF plus other FAE, while both were significantly more effective than a placebo, there was no significant difference between them, indicating that DMF is the active ingredient in terms of efficacy